1H-[1,2,3]TRIAZOLO[4,5-H]QUINAZOLINE COMPOUNDS AS PROTEIN KINASE INHIBITORS
Publication
EP4711369A1
Kind: A1
Mar 18, 2026
Applicants
Chengdu Cynogen Bio-Pharmaceutical Technology Co., Ltd.
Inventors
CHENG, Hang, XIONG, Weiyan, SHI, Pengyi, NIU, Wei, YU, Bin, JIANG, Yu
Abstract
Provided are 1H-[1,2,3]triazolo[4,5-H]quinazoline compounds of general formula (I), and the compounds can be used for treating cell proliferation disorders. The compounds are effective inhibitors of cyclin-dependent kinases (CDKs).
IPC Classifications
C07D 487/14 20060101AFI20241206BHEP
A61K 31/517 20060101ALI20241206BHEP
A61P 35/00 20060101ALI20241206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR